Far Infrared Radiation Treatment for Osteoarthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00573352|
Recruitment Status : Unknown
Verified January 2009 by GAAD Medical Research Institute Inc..
Recruitment status was: Active, not recruiting
First Posted : December 14, 2007
Last Update Posted : January 5, 2009
|Condition or disease||Intervention/treatment||Phase|
|Osteoarthritis||Radiation: Far Infrared||Phase 1|
Arthritis consists of more than 100 different conditions. These conditions range from relatively mild forms such as tendonitis and bursitis to crippling forms as rheumatoid arthritis. Pain syndromes include fibromyalgia and arthritis-related disorders as lupus erythematosus that involve every part of the body. There are forms of the disease, such as gout that almost nobody connects with arthritis. Osteoarthritis is the most common form of arthritis.
The objective for the study is to access the possibility of using far infrared radiation for pain management.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Phase 1 Study to Determine the Efficacy of Using Energy Specific Far Infrared (FIR) Radiation for the Treatment of Arthritis and Other Related Diseases|
|Study Start Date :||September 2006|
|Actual Primary Completion Date :||February 2008|
|Estimated Study Completion Date :||December 2008|
Far infrared radiation
Radiation: Far Infrared
Far Infrared Radiation (5μm to 20μm wavelength). Duration is 30 to 40 minutes per session
- The primary end point is to determine the therapeutic effects of far infrared radiation on osteoarthritis [ Time Frame: 2 years and 9 months ]
- The therapeutic effects of far infrared radiation on all forms of arthritis [ Time Frame: 2 years and 9 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00573352
|The Centre for Incurable Diseases|
|Toronto, Ontario, Canada, M4V 1L5|
|Study Director:||Kwasi Donyina, Ph.D.||GAAD Medical Research Institute Inc.|
|Principal Investigator:||Ken Nedd, M.D.||GAAD Medical Research Institute Inc.|